Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health insurance; if prior authorization request is approved for prescription drugs. | Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134. | us/states/va | Virginia General Assembly | 2024 | SB 98 | Virginia SB 98 (2024) |
|
enacted |
|
4 | 33 | 6 | 2024-01-02 | 2024-04-02 | openstates | ocd-bill/30ff2f8e-54e8-422c-9041-f6fe858cbf1d | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB98 | 1b5fcb469f48e1c51831ec4c2c141009cde99574c81026ed613421dc71c9bcb8 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 98 (2024) — Health insurance; if prior authorization request is approved for prescription drugs.
Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0338 (committee substitute) — source
- Committee substitute printed 24105929D-S1 (committee substitute) — source
- Prefiled and ordered printed; offered 01/10/24 24101001D (committee substitute) — source
- SB98ER (committee substitute) — source
Votes
- Reported from Labor and Commerce with amendment(s) (22-Y 0-N) — 22–0 (pass) · lower
- VOTE: Block Vote Passage (98-Y 0-N) — 97–0 (pass) · lower
- Read third time and passed Senate (38-Y 0-N) — 38–0 (pass) · upper
- House amendment agreed to by Senate (39-Y 0-N) — 39–0 (pass) · upper
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Commerce and Labor with substitute (15-Y 0-N) — 15–0 (pass) · upper
Sponsors
- Barbara A. Favola — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-02 Prefiled and ordered printed; offered 01/10/24 24101001D
filing, introduction - 2024-01-02 Referred to Committee on Commerce and Labor
referral-committee - 2024-01-22 Senate committee, floor amendments and substitutes offered
- 2024-01-22 Reported from Commerce and Labor with substitute (15-Y 0-N)
committee-passage - 2024-01-22 Committee substitute printed 24105929D-S1
substitution - 2024-01-24 Impact statement from SCC (SB98)
- 2024-01-24 Constitutional reading dispensed (40-Y 0-N)
- 2024-01-25 Read second time
reading-2 - 2024-01-25 Reading of substitute waived
- 2024-01-25 Committee substitute agreed to 24105929D-S1
substitution - 2024-01-25 Engrossed by Senate - committee substitute SB98S1
substitution - 2024-01-26 Read third time and passed Senate (38-Y 0-N)
passage, reading-3 - 2024-01-29 Impact statement from SCC (SB98S1)
- 2024-02-13 Placed on Calendar
- 2024-02-13 Read first time
reading-1 - 2024-02-13 Referred to Committee on Labor and Commerce
referral-committee - 2024-02-20 Reported from Labor and Commerce with amendment(s) (22-Y 0-N)
committee-passage - 2024-02-22 Read second time
reading-2 - 2024-02-23 Read third time
reading-3 - 2024-02-23 Committee amendment agreed to
amendment-passage - 2024-02-23 Engrossed by House as amended
- 2024-02-23 Passed House with amendment BLOCK VOTE (98-Y 0-N)
passage - 2024-02-23 VOTE: Block Vote Passage (98-Y 0-N)
passage - 2024-02-27 House amendment agreed to by Senate (39-Y 0-N)
amendment-passage - 2024-03-04 Enrolled
enrolled - 2024-03-04 Bill text as passed Senate and House (SB98ER)
passage - 2024-03-04 Signed by Speaker
passage - 2024-03-07 Signed by President
passage - 2024-03-08 Impact statement from SCC (SB98ER)
- 2024-03-11 Enrolled Bill Communicated to Governor on March 11, 2024
enrolled - 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024
executive-receipt - 2024-04-02 Approved by Governor-Chapter 338 (effective 7/1/24)
executive-signature - 2024-04-02 Acts of Assembly Chapter text (CHAP0338)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/30ff2f8e-54e8-422c-9041-f6fe858cbf1d. Confidence: reported (aggregated from official Virginia legislature records).